フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing...
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to...
Cesca Therapeutics To Present At The 2019 Bio Investor Forum PR Newswire RANCHO CORDOVA, Calif., Oct. 14, 2019 RANCHO CORDOVA, Calif., Oct. 14...
Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee PR Newswire RANCHO CORDOVA, Calif., Oct. 2, 2019 RANCHO CORDOVA...
ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices PR Newswire RANCHO CORDOVA, Calif., Sept. 25, 2019 RANCHO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendm...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
As filed with the Securities and Exchange Commission on September 12, 2019 ...
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products PR Newswire RANCHO...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約